Back to Search
JAMES BREITENBUCHER, MD
MD
Nephrology Physician
NPI: 1902151780Individual
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
20775(MN)
Research & Publications (20)
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
PMID 19095868·Anesth Analg·2009
4-observational
Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
PMID 18983142·J Med Chem·2008
6-review
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase.
PMID 18693015·Bioorg Med Chem Lett·2008
4-observational
Role of CCK and potential utility of CCK1 receptor antagonism in the treatment of pancreatitis induced by biliary tract obstruction.
PMID 18297100·Br J Pharmacol·2008
4-observational
Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH).
PMID 18289847·Bioorg Med Chem Lett·2008
7-preclinical
2-Aryl benzimidazoles featuring alkyl-linked pendant alcohols and amines as inhibitors of checkpoint kinase Chk2.
PMID 17937984·Bioorg Med Chem Lett·2007
4-observational
SAR studies of 1,5-diarylpyrazole-based CCK1 receptor antagonists.
PMID 17933530·Bioorg Med Chem Lett·2007
4-observational
3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumide.
PMID 17684117·J Pharmacol Exp Ther·2007
4-observational
Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase.
PMID 17279740·J Med Chem·2007
7-preclinical
Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands.
PMID 16990005·Bioorg Med Chem Lett·2006
8-other
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms.
PMID 16501580·Br J Pharmacol·2006
4-observational
Pyrazole CCK(1) receptor antagonists. Part 1: Solution-phase library synthesis and determination of Free-Wilson additivity.
PMID 16236513·Bioorg Med Chem Lett·2006
8-other
Pyrazole CCK(1) receptor antagonists. Part 2: SAR studies by solid-phase library synthesis and determination of Free-Wilson additivity.
PMID 16236506·Bioorg Med Chem Lett·2006
8-other
Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles.
PMID 15771432·J Med Chem·2005
8-other
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.
PMID 15771431·J Med Chem·2005
7-preclinical
Dihydropyridine neuropeptide Y Y1 receptor antagonists 2. bioisosteric urea replacements.
PMID 14723969·Bioorg Med Chem·2004
8-other
The impact of combinatorial chemistry on drug discovery.
PMID 12951813·Curr Opin Drug Discov Devel·2003
6-review
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors.
PMID 12742021·J Mol Biol·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2450 RIVERSIDE AVE, ADMINISTRATION
MINNEAPOLIS, MN 55454 - Phone
- (612) 273-6086
Quick Facts
- NPI
- 1902151780
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile